• No results found

Towards clinical implementation of personalised PRRT in patients with neuroendocrine tumours

N/A
N/A
Protected

Academic year: 2021

Share "Towards clinical implementation of personalised PRRT in patients with neuroendocrine tumours"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

VU Research Portal

Towards clinical implementation of personalised PRRT in patients with neuroendocrine tumours

Huizing, D.M.V.

2021

document version

Publisher's PDF, also known as Version of record

Link to publication in VU Research Portal

citation for published version (APA)

Huizing, D. M. V. (2021). Towards clinical implementation of personalised PRRT in patients with neuroendocrine tumours: Optimisation of nuclear imaging techniques, dosimetry and response evaluation.

General rights

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.

• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.

• You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal ?

Take down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

E-mail address:

vuresearchportal.ub@vu.nl

Download date: 11. Oct. 2021

(2)

Towards clinical implementation of personalised PRRT in patients with neuroendocrine tumours Daphne Huizing

Towards clinical implementation of personalised PRRT in patients with neuroendocrine tumours

Optimisation of nuclear imaging techniques, dosimetry and response evaluation

Daphne Huizing

Referenties

GERELATEERDE DOCUMENTEN

9 Over the recent years, the use of cardiac innervation imaging with 123I-metaiodobenzylguanidine (MIBG) and planar imaging or SPECT has been evaluated for risk stratifi- cation

This increased endoglin tissue expression in tumours was significantly related to the tumour’s size, the presence of metastases and a more advanced tumour

‘carcinoid’ should be used solely in the clinical setting, and only for those tumours that lead to the carcinoid syndrome as a result of the hypersecretion of serotonin,

Percutaneous radiofrequency ablation of recurrences of colorectal liver metastases after previous liver surgery is often the only remaining treat- ment modality with potential

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of

De ambitie is dat door middel van dit onderzoek posttherapie dosimetrie en responsevaluatie na PRRT wordt geoptimaliseerd, om zo uiteindelijk te kunnen zorgen voor

The aim of this thesis was to quantify and harmonise nuclear imaging techniques for patients with neuroendocrine tumours (NETs), and to identify parameters associated with

Towards clinical implementation of personalised PRRT in patients with neuroendocrine tumours: Optimisation of nuclear imaging techniques, dosimetry and response evaluation.